Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01055795 | Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors(BEL) | completed | Phase 1 | 14 | Herbert HurwitzOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01755390 | A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | SanofiINDUSTRY | 2 | Dec 24, 2012 | clinicaltrials |
| NCT01336582 |
| Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer |
| completed |
| Phase 1 |
| 42 |
| Samyang Biopharmaceuticals CorporationINDUSTRY |
| 1 |
| Dec 21, 2012 |
| clinicaltrials |
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
| NCT01748019 | ST1968 Intravenous (Weekly) in Solid Tumors | completed | Phase 1 | 62 | sigma-tau i.f.r. S.p.A.INDUSTRY | 0 | Dec 12, 2012 | clinicaltrials |
| NCT00349167 | PR-104 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Proacta, IncorporatedINDUSTRY | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | completed | Phase 1 | 58 | City of Hope Medical CenterOTHER | 0 | Nov 22, 2012 | clinicaltrials |
| NCT00840190 | A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies(Serenity) | completed | Phase 1 | 29 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 21, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00551889 | Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer | completed | Phase 1 | 57 | City of Hope Medical CenterOTHER | 0 | Nov 12, 2012 | clinicaltrials |
| NCT00003132 | Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00004002 | PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00005990 | R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00003021 | Bizelesin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00697502 | Study of Capecitabine In Patients With Solid Tumors | completed | Phase 1 | 23 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00005844 | Oxaliplatin in Treating Children With Advanced Solid Tumors | completed | Phase 1 | 26 | St. Jude Children's Research HospitalOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00495872 | Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor | completed | Phase 1 | 204 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00752011 | Phase I Study of TAS-106 in Combo With Carboplatin | completed | Phase 1 | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 18, 2012 | clinicaltrials |
| NCT01158079 | Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment | completed | Phase 1 | 7 | Alnylam PharmaceuticalsINDUSTRY | 2 | Oct 12, 2012 | clinicaltrials |
| NCT00093730 | BMS-599626 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 9 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | completed | Phase 1 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00004886 | MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT01041235 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | completed | Phase 1 | 29 | Azaya Therapeutics, Inc.INDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00482521 | CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment | completed | Phase 1 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT00920595 | Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | CephalonINDUSTRY | 2 | Aug 16, 2012 | clinicaltrials |
| NCT00003708 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 32 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003709 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003710 | Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003712 | CCI-779 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00251407 | Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies | completed | Phase 1 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT01098838 | Safety and Efficacy of LCL161 in Patients With Solid Tumors | completed | Phase 1 | 71 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 3, 2012 | clinicaltrials |
| NCT00502892 | Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | completed | Phase 1 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00509782 | Phase I Trial of ZIO-101 in Patients With Solid Tumors | completed | Phase 1 | 47 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | completed | Phase 1 | 63 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00508807 | RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies | completed | Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00006354 | Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | 41 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 24, 2012 | clinicaltrials |
| NCT00027677 | Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 24, 2012 | clinicaltrials |
| NCT01170975 | Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules | completed | Phase 1 | 12 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00874042 | Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 74 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Jul 23, 2012 | clinicaltrials |
| NCT00591136 | Phase I Study of Indibulin in Patients With Solid Tumors | completed | Phase 1 | 47 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00591396 | A Phase I Trial of ZIO-101 in Solid Tumors | completed | Phase 1 | 40 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT01139346 | Study of Oral Darinaparsin in Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00005061 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 20 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 18, 2012 | clinicaltrials |
| NCT00006477 | Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors | completed | Phase 1 | 26 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00793897 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 21 | Bristol-Myers SquibbINDUSTRY | 3 | Jul 13, 2012 | clinicaltrials |
| NCT00003976 | E7070 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003981 | E7070 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003982 | MEN-10755 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00731263 | A Study of Tor Kinase Inhibitor in Advanced Tumors | completed | Phase 1 | 64 | AstraZenecaINDUSTRY | 3 | Jul 11, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Dec 24, 2012source: clinicaltrials